Inspire Medical Systems, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Inspire Medical Systems, Inc. (INSP) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$293.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-03
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$293.00K, a 273.37% decline year-over-year.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$816.00K.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $243.00K, a 86.61% decline year-over-year.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $169.00K.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$72.00K.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$264.00K, a 129.80% decline from fiscal 2023.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $886.00K.
- Inspire Medical Systems, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$31.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$293.00K 10-Q · filed 2026-08-03 | -$1.11M derived: sum of 2 quarters · filed 2026-08-03 | ||
| 2026-03-31 | -$816.00K 10-Q · filed 2026-08-03 | |||
| 2025-12-31 | -$72.00K 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $243.00K 10-Q · filed 2025-11-03 | $412.00K derived: sum of 2 quarters · filed 2026-08-03 | $103.00K derived: sum of 3 quarters · filed 2026-08-03 | |
| 2025-06-30 | $169.00K 10-Q · filed 2026-08-03 | -$140.00K derived: sum of 2 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$309.00K 10-Q · filed 2026-08-03 | |||
| 2024-12-31 | -$264.00K 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $1.81M 10-Q · filed 2025-11-03 | $1.58M derived: sum of 2 quarters · filed 2025-11-03 | $900.00K derived: sum of 3 quarters · filed 2025-11-03 | |
| 2024-06-30 | -$239.00K 10-Q · filed 2025-11-03 | -$915.00K derived: sum of 2 quarters · filed 2025-11-03 | ||
| 2024-03-31 | -$676.00K 10-Q · filed 2025-11-03 | |||
| 2023-12-31 | $886.00K 10-K · filed 2026-02-13 | |||
| 2023-09-30 | -$59.00K 10-Q · filed 2024-11-04 | $12.00K derived: sum of 2 quarters · filed 2024-11-04 | $130.00K derived: sum of 3 quarters · filed 2024-11-04 | |
| 2023-06-30 | $71.00K 10-Q · filed 2024-11-04 | $189.00K derived: sum of 2 quarters · filed 2024-11-04 | ||
| 2023-03-31 | $118.00K 10-Q · filed 2024-11-04 | |||
| 2022-12-31 | -$31.00K 10-K · filed 2025-02-10 | |||
| 2022-09-30 | -$162.00K 10-Q · filed 2023-11-07 | -$165.00K derived: sum of 2 quarters · filed 2023-11-07 | -$308.00K derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$3.00K 10-Q · filed 2023-11-07 | -$146.00K derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | -$143.00K 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | -$84.00K 10-K · filed 2024-02-09 | |||
| 2021-09-30 | $3.00K 10-Q · filed 2022-11-01 | -$18.00K derived: sum of 2 quarters · filed 2022-11-01 | -$38.00K derived: sum of 3 quarters · filed 2022-11-01 | |
| 2021-06-30 | -$21.00K 10-Q · filed 2022-11-01 | -$41.00K derived: sum of 2 quarters · filed 2022-11-01 | ||
| 2021-03-31 | -$20.00K 10-Q · filed 2022-11-01 | |||
| 2020-12-31 | -$73.00K 10-K · filed 2023-02-10 | |||
| 2020-09-30 | -$81.00K 10-Q · filed 2021-11-02 | -$222.00K derived: sum of 2 quarters · filed 2021-11-02 | -$29.00K derived: sum of 3 quarters · filed 2021-11-02 | -$17.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$141.00K 10-Q · filed 2021-11-02 | $52.00K derived: sum of 2 quarters · filed 2021-11-02 | $64.00K derived: sum of 3 quarters · filed 2022-02-15 | $103.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $193.00K 10-Q · filed 2021-11-02 | $205.00K derived: sum of 2 quarters · filed 2022-02-15 | $244.00K derived: sum of 3 quarters · filed 2022-02-15 | $279.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $51.00K derived: sum of 2 quarters · filed 2022-02-15 | $86.00K derived: sum of 3 quarters · filed 2022-02-15 | $154.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | $39.00K 10-Q · filed 2020-11-02 | $74.00K derived: sum of 2 quarters · filed 2020-11-02 | $142.00K 10-Q · filed 2019-11-05 | $116.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $35.00K 10-Q · filed 2020-11-02 | $103.00K 10-Q · filed 2019-08-06 | $77.00K derived: sum of 3 quarters · filed 2021-02-24 | $51.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $68.00K 10-Q · filed 2020-11-02 | $42.00K derived: sum of 2 quarters · filed 2021-02-24 | $16.00K derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$52.00K derived: sum of 2 quarters · filed 2021-02-24 | -$52.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$26.00K 10-Q · filed 2019-11-05 | -$26.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |